Click & Collect now available!
This is a Pharmacy Medicine, therefore you'll need to answer a few short questions so our pharmacy team can ensure this product is right for you.
Please note images are for illustration purposes and may differ from the product(s) you receive
MigraKind film-coated tablets are indicated for the acute relief of migraine attacks, with or without aura. MigraKind film-coated tablets should only be used where there is a clear diagnosis of migraine.
Adults only.
Important information regarding the ingredients in this medicine Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption should not take this medicine.
MigraKind should only be used where there is a clear diagnosis of migraine.
Like all medicines, this medicine can cause side effects, although not everybody gets them. If any of the side effects get worse, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Nervous System Disorders: Common: Dizziness, drowsiness, sensory disturbance including paraesthesia and hypoaesthesia.
Vascular Disorders: Common: Transient increases in blood pressure arising soon after treatment. Flushing.
Respiratory, Thoracic and Mediastinal Disorders: Common: Dyspnoea.
Gastrointestinal Disorders: Common: Nausea and vomiting occurred in some patients but it is unclear if this is related to sumatriptan or the underlying condition.
Musculoskeletal and Connective Tissue Disorders Common: Sensations of heaviness (usually transient and may be intense and can affect any part of the body including the chest and throat). Myalgia.
General Disorders and Administration Site Conditions: Common: Pain, sensations of heat or cold, pressure or tightness ( these events are usually transient and may be intense and can affect any part of the body including the chest and throat: Feelings of weakness, fatigue (both events are mostly mild to moderate in intensity and transient).
Adults (18-65 years of age).
Patients who do not respond to the prescribed dose of MigraKind should not take a second dose for the same attack. In these cases the attack can be treated with paracetamol, acetylsalicylic acid, or non-steroidal anti-inflammatory drugs. MigraKind may be taken for subsequent attacks.
Each film coated tablet contains 50 mg sumatriptan (as the succinate).
Excipient with known effect: each tablet contains 180.02 mg of lactose, as the anhydrous and monohydrate forms.
Tablet core: Lactose monohydrate, Croscarmellose sodium, Microcrystalline cellulose, Lactose, Magnesium stearate.
Film coating: Lactose monohydrate, Mannitol (E421), Titanium dioxide (E171), Triacetin, Talc.
94% of orders are despatched within 2 days (data taken from July 2022 to October 2022)
Additional terms and conditions apply, to view our full delivery terms and conditions click here
If you're not completely satisfied with your order, you can return it to us within 28 days
Find out more about our returns policy click here